Skip to main content
. 2019 Jun 30;45(2):134–141. doi: 10.12865/CHSJ.45.02.02

Figure 1.

Figure 1

Image of adenocarcinoma with intense positive reaction to p53 (Anti-p53 antibody immunostaining, x200)